China vaccine manufacturer, Sinovac, said his vaccine was still effective against the Corona virus virus varian Delta.
“This vaccine does not provide 100 percent protection but can still be effective in preventing severity and death,” the company wrote, quoted by the China Global Times media, Saturday (26/6/2021).
Wei Sheng, a professor at Tongji Medical College’s School of Public Health, Huazhong University of Science and Technology, said in an interview with CCTV that according to the latest trial results, widely administered vaccines including the Sinovac vaccine are still effective against the Delta variant.
This, he said, could be seen from the experience of preventing and controlling the Corona epidemic in Guangzhou, South China’s Guangdong Province. The risk of severe disease is greatly reduced compared to those who have not been vaccinated.
“This shows the vaccine is protective,” Wei said.
So far, the majority of vaccination programs in Indonesia use the Sinovac vaccine obtained through a bilateral scheme with China.
In phase 3 clinical trials conducted in Indonesia, the Sinovac vaccine had 65 percent efficacy. A study conducted by the Ministry of Health also stated that the Sinovac vaccine was effective in reducing severe symptoms in health workers by up to 94 percent.
Watch Videos”The third injection of Sinovac vaccine is claimed to increase immunity by 20 times 20“
[Gambas:Video 20detik]
(kna / kna)
– .
